Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTransense Regulatory News (TRT)

Share Price Information for Transense (TRT)

Share Price is delayed by 15 minutes
Get Live Data
55.50    -0.50 (-0.89%)
Bid:
55.00
Ask:
56.00
Spread: 1.00 (1.818%)
Market Cap: £8.45m
TRT Live PriceLast checked at - London Stock Exchange

Intraday Transense Share Chart

Trading Statement

13 Jun 2014 07:00

RNS Number : 5364J
Transense Technologies PLC
13 June 2014
 

13 June 2014

Transense Technologies plc("Transense" or the "Company")

Trading Statement

Transense provides the following update on current trading and expected performance for the year ending on 30 June 2014.

The Board has been greatly encouraged by the volume of sales activity during the current financial year and anticipates that final sales for the year will be not less than £3.5m, which will exceed last year by more than 130%. This figure is lower than that anticipated at the time of announcing the Company's interim figures in early February. At that time, management information indicated that growth in the second half of the year would enable full year expectations to be met. However, the length of the sales cycle has proven greater than expectedEssentially all of the unconverted sales prospects that formed the basis for market guidance remain active and we remain confident that we will continue to achieve substantial increases in turnover year-on-year.

The market opportunities for Transense's products remain large and attractive, with new distribution channels established or being established in China, Japan, Chile, Columbia and Malaysia in recent months, incorporating a direct presence via sales channel support.

The delays in placement of certain new orders is expected to result in an EBITDA loss for the current year, rather than the previously anticipated breakeven result. However, given the encouraging trends in the business including the strong top line growth, robust gross margins in line with expectations and better-than-expected overheads, the EBITDA loss for this financial year will be less than half that sustained in the previous year.

 The pipeline includes a number of substantial potential new orders at an advanced stage of discussion. As the installed base of customers continues to grow, Transense expects to benefit over the longer term from higher levels of repeat orders of replacement items such as its tyre probes. However, larger individual contracts may still continue to cause some volatility in reported results. A further update on progress across all divisions will be given at the time of the full year results in September.

The Company's cash position remains strong at £3.2m and the Directors continue to believe that the business has sufficient capital required to pursue the business plan and deliver significant growth in the years ahead.

For more information please contact:

 

Transense Technologies plc

Graham Storey, Chief Executive

Tel: +44 1869 238 380

 

N+1 Singer - Nominated Adviser & Broker

Aubrey Powell

Alex Wright

 

Tel: +44 20 7496 3000

 

Newgate Threadneedle

Caroline Forde, Robyn McConnachie

 

Tel: +44 20 7653 9850

 

 

About Transense Technologies

 

 

Based in Oxfordshire, UK, Transense has developed patent-protected sensor systems and supporting technology for use in a variety of diverse high growth markets. Transense's Surface Acoustic Wave (SAW), wireless, battery-less, sensor systems offer significant advantages over legacy wireless sensor systems. Transense is targeting the global electrical Smart Grid applications market, the transport and mining industries, and the global torque, temperature and pressure sensing markets, via its three trading divisions, IntelliSAW, Translogik and the newly established SAWSense, respectively.

Transense's shares are admitted to trading on AIM, a market operated by the London Stock Exchange (AIM: "TRT").

 

Transense's sensors are also being used in the wind turbine monitoring industry. The Company is part of a consortium of nine companies ("IntelWind") that has begun development on a major EU funded project to improve the efficiency and reliability of wind turbines.

 

Transense's shares are admitted to trading on AIM, a market operated by the London Stock Exchange (AIM: "TRT").

 

www.transense.co.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTVLLFFZQFXBBZ
Date   Source Headline
27th May 20227:00 amRNSTransaction in own shares & TVR
26th May 20223:57 pmRNSHolding(s) in Company
24th May 20227:15 amRNSTransaction in own shares & TVR
19th May 20227:00 amRNSTransaction in Own Shares & TVR
17th May 20227:00 amRNSTRT wins place on TDAP & £135k Grant
16th May 20227:00 amRNSTransaction in Own Shares & TVR
11th May 20227:00 amRNSSAW Update
9th May 20227:00 amRNSTransaction in own shares & TVR
3rd May 20227:00 amRNSTransaction in own shares & TVR
26th Apr 20228:54 amRNSTransaction in Own Shares
19th Apr 20227:00 amRNSTransaction in Own Shares
2nd Mar 20225:15 pmRNSHolding(s) in Company
28th Feb 20227:00 amRNSDirector/PDMR - acquisition of shares
22nd Feb 20227:02 amRNSGrant of share options to employees
22nd Feb 20227:01 amRNSShare Repurchase Programme
22nd Feb 20227:00 amRNSInterim Results & Investor Presentation
31st Jan 20227:00 amRNSNotice of Results & Investor Presentation
23rd Dec 20212:51 pmRNSHolding(s) in Company
22nd Dec 20214:11 pmRNSDirector/PDMR Shareholding
7th Dec 20214:25 pmRNSDirector/PDMR Shareholding
30th Nov 20217:00 amRNSDirector/PDMR Shareholding - Acquisition of Shares
24th Nov 20217:00 amRNSDirector/PDMR shareholding – acquisition of shares
23rd Nov 202112:47 pmRNSResult of AGM
23rd Nov 20217:00 amRNSAGM Trading Update and Director Appointments
11th Nov 202111:40 amRNSHolding(s) in Company
2nd Nov 20217:01 amRNSAppointment of Additional SAWCAP Member
2nd Nov 20217:00 amRNSAGM Attendance & Investor Presentation
27th Oct 20217:00 amRNSAnnual Report, Notice of AGM & Investor Pres
4th Oct 20217:00 amRNSGrant of Options/PDMR Dealing
28th Sep 20217:00 amRNSFinal Results & Investor Presentation
14th Sep 20217:00 amRNS5 year JCA with McLaren Applied Ltd for SAW Tech
3rd Sep 20214:38 pmRNSHolding(s) in Company
31st Aug 20215:00 pmRNSTotal Voting Rights
26th Aug 20217:00 amRNSNotice of Annual Results & Investor Presentation
18th Aug 20213:30 pmRNSExercise of warrants
23rd Jul 20217:00 amRNSDirector/PDMR Shareholding
21st Jul 20217:00 amRNSNew member of Commercial Advisory Panel
5th Jul 20217:00 amRNSYear End Trading Update
2nd Jul 20211:12 pmRNSHolding(s) in Company
23rd Jun 20217:00 amRNSDirector/PDMR Shareholding
9th Apr 202110:05 amRNSHolding(s) in Company
15th Mar 20217:00 amRNSHolding(s) in Company
19th Feb 20214:12 pmRNSHolding(s) in Company
18th Feb 20211:21 pmRNSDirector/PDMR shareholding
17th Feb 202110:34 amRNSDirector/PDMR shareholding
17th Feb 20217:00 amRNSInterim Results & Investor Presentation
12th Feb 202112:48 pmRNSFurther re. Completion of Capital Reduction
1st Feb 20217:00 amRNSNotice of Results & Investor Presentation
28th Jan 20217:00 amRNSCompletion of Capital Reduction
21st Dec 20207:00 amRNSIssue of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.